FOXP3 can modulate TAL1 transcriptional activity through interaction with LMO2

Area of Science:

• Oncology
• Molecular Biology
• Gene Regulation

Background:

• T-cell acute lymphoblastic leukemia (T-ALL) is often driven by aberrant TAL1 and LMO2 expression, crucial for thymocyte transformation.
• The transcription factor FOXP3 is found in various cancers, including T-ALL, suggesting a potential role.

Purpose of the Study:

• To investigate the role of FOXP3 in T-ALL pathogenesis.
• To elucidate the molecular mechanisms by which FOXP3 influences T-ALL cells.

Main Methods:

• Analysis of FOXP3 expression correlation with TAL1-complex target genes in T-ALL patient samples and cell lines.
• Assessment of cell cycle progression and viability in FOXP3-expressing T-ALL cells.
• In vitro binding assays to study FOXP3 and LMO2/TAL1 interactions.

Main Results:

• Increased FOXP3 levels inversely correlated with TAL1-complex target gene expression in T-ALL.
• FOXP3 expression altered cell cycle regulation and decreased viability in T-ALL cells.
• FOXP3 directly binds LMO2, disrupting the LMO2-TAL1 interaction.

Conclusions:

• FOXP3 functions as a tumor suppressor in T-ALL.
• FOXP3 modulates TAL1 transcriptional activity, offering a novel therapeutic target for T-ALL.